Notice of Intent to Sole Source - Abbott Laboratories Inc. - Fort Jackson, SC
Defense Health Agency · DEFENSE HEALTH AGENCY
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation PANHCA26P0000031152 in this department, oldest first.
- Aug 19, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Notice of Intent to Sole Source This notice is being published in accordance with Revolutionary FAR Overhaul (RFO) Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a Notice of Intent to Sole Source and is not a request for competitive quotes/proposals. The Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast (DHACA-HCD-SE) is issuing this Notice of Intent (NOI) to inform industry contractors of the Government�s intent to execute a Sole Source out-of-scope bilateral modification to a… (show all)
n existing Firm-Fixed-Price, commercial Cost-Per-Reportable-Result (CPRR) contract, W91YTZ25C0003, awarded to Abbott Laboratories, Inc., for Moncrief Army Health Clinic, Fort Jackson, South Carolina. In accordance with RFO FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. This contract action is to increase the estimated quantities and overall ceiling funding for Option years 1, 2, 3, and 4 for Chemistry/Immunochemistry analyzers, reagents, consumables, calibrations, and control material, in support of Defense Health Agency and Department of the Army mission. The North American Industry Classification System (NAICS) for this requirement is 325413, In-vitro diagnostic substances manufacturing. The Small Business Administration (SBA) size standard is 1,250 employees. The Product/Service Code (PSC) is?6550, In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. This NOI is neither a formal solicitation, nor a request for competitive proposals. No solicitation document is available, and telephone requests will not be honored. No award will be made based on unsolicited quotations or offers received in response to this notice. Any response to this notice must show clear, compelling, and convincing evidence that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct competitive procurement. A determination by the Government to not compete this action based on this notice is solely within the discretion of the Government. All inquiries and concerns must be addressed in writing via email to Donna Rodriguez, email: donna.d.rodriguez.civ@health.mil and Mary Shifflett, email: mary.e.shifflett2.civ@health.mil. All interested parties who are responsible, certified, and capable may identify their interest and may submit a Capabilities Statement on company letterhead no later than 12:00 P.M., Eastern Daylight Time (EDT), on September 2, 2026, to the above listed contacts. The interested parties bear full responsibility to ensure complete, timely transmission and confirmation of receipt.
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY), same product/service code (PSC) 6550 and NAICS 325413.
Single-winner award sizes (3): middle half $554K to $2.7M, median $837K; range $271K to $4.5M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ABBOTT LABORATORIES INC. · $ABT · $40.1B | 1 | $4.5M | Mar 10, 2026 |
| QUIDELORTHO SALES COMPANY · $QDEL · $3.0B | 1 | $837K | May 27, 2026 |
| WERFEN USA LLC | 1 | $271K | Jan 5, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $ABT reported $40.1B revenue in FY2025. The median single-winner award in these 3 past awards, $837K, is under 0.1% of that. 10-K
- $QDEL reported $3.0B revenue in FY2025. The median single-winner award in these 3 past awards, $837K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- May 27, 2026QUIDELORTHO SALES COMPANY$837KQuidel Ortho Reagents, Consumables and MaintenanceMateriality: 0.03% of $QDEL revenue (Low) SEC
- Mar 10, 2026ABBOTT LABORATORIES INC.$4.5MChemistry Analyzer and Reagents Keesler AFBMateriality: 0.01% of $ABT revenue (Low) SEC
- Jan 5, 2026WERFEN USA LLC$271KCoagulation Analyzers and Reagents Keesler AFBNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (4 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- $46K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Armed Services, Senate Committee on Appropriations, Senate Committee on Armed Services
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 2 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.